About
I'm a finance and analytics professional with experience in financial modeling, risk analysis, data analytics, and market research. My work centers on structuring problems clearly: building models, analyzing data, and producing research that supports business decisions.
Recent Work
Pharmaceutical Product Concentration: Measuring Revenue Dependence in Major U.S. Drugmakers
concentration risk · CR3 · CR5 · HHI · pharma
This working paper quantifies how concentrated pharmaceutical revenues have become among the five largest U.S.-listed drug manufacturers—AbbVie, Bristol Myers Squibb, Johnson & Johnson, Merck, and Pfizer. Using public segment disclosures from 2022–2024, the study applies conventional concentration metrics (CR3, CR5, HHI) and introduces interval-bounded estimates to account for the opacity of aggregated "Other" revenue categories.
FMWC 100% Solution – EV Charging Station Financial Model
Project finance · DCF · Debt modeling · Sensitivity-ready
A fully integrated project finance DCF model of an EV charging station business, including detailed construction capex, equipment costs, operating cash flows, debt drawdown and amortization, and monthly projections from 2021–2030.
Marketing-Driven E-commerce Brand Financial Model
Project finance · Marketing Mix Modeling (MMM) · Online Retail P&L
A fully integrated project finance–style model of an e-commerce business, using marketing spend as the core investment driver. Includes monthly projections of ad spend, customer acquisition, orders, revenues, COGS, gross profit, operating expenses, and EBITDA, with scenario toggles and sensitivity structure.